These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 24860498)
1. Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson's disease. Benazzouz A; Mamad O; Abedi P; Bouali-Benazzouz R; Chetrit J Front Aging Neurosci; 2014; 6():87. PubMed ID: 24860498 [TBL] [Abstract][Full Text] [Related]
2. Extrastriatal dopaminergic circuits of the Basal Ganglia. Rommelfanger KS; Wichmann T Front Neuroanat; 2010; 4():139. PubMed ID: 21103009 [TBL] [Abstract][Full Text] [Related]
3. Chapter 33: the history of movement disorders. Lanska DJ Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136 [TBL] [Abstract][Full Text] [Related]
4. Role of the globus pallidus in motor and non-motor symptoms of Parkinson's disease. Jiang Y; Qi Z; Zhu H; Shen K; Liu R; Fang C; Lou W; Jiang Y; Yuan W; Cao X; Chen L; Zhuang Q Neural Regen Res; 2025 Jun; 20(6):1628-1643. PubMed ID: 38845220 [TBL] [Abstract][Full Text] [Related]
5. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. During MJ; Kaplitt MG; Stern MB; Eidelberg D Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246 [TBL] [Abstract][Full Text] [Related]
6. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients. Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033 [TBL] [Abstract][Full Text] [Related]
7. Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine? Villalba RM; Smith Y Neuroscience; 2013 Oct; 251():2-20. PubMed ID: 23867772 [TBL] [Abstract][Full Text] [Related]
8. Substantia nigra compacta neurons that innervate the reticular thalamic nucleus in the rat also project to striatum or globus pallidus: implications for abnormal motor behavior. Anaya-Martinez V; Martinez-Marcos A; Martinez-Fong D; Aceves J; Erlij D Neuroscience; 2006 Dec; 143(2):477-86. PubMed ID: 17008017 [TBL] [Abstract][Full Text] [Related]
9. Cellular and Synaptic Dysfunctions in Parkinson's Disease: Stepping out of the Striatum. Mallet N; Delgado L; Chazalon M; Miguelez C; Baufreton J Cells; 2019 Aug; 8(9):. PubMed ID: 31470672 [TBL] [Abstract][Full Text] [Related]
10. Synaptic and cellular plasticity in Parkinson's disease. Chu HY Acta Pharmacol Sin; 2020 Apr; 41(4):447-452. PubMed ID: 32112041 [TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder. Wichmann T; DeLong MR Ann N Y Acad Sci; 2003 Jun; 991():199-213. PubMed ID: 12846988 [TBL] [Abstract][Full Text] [Related]
12. Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson's disease. Milosevic L; Gramer R; Kim TH; Algarni M; Fasano A; Kalia SK; Hodaie M; Lozano AM; Popovic MR; Hutchison WD Neurobiol Dis; 2019 Apr; 124():46-56. PubMed ID: 30391540 [TBL] [Abstract][Full Text] [Related]
13. Dysregulation of external globus pallidus-subthalamic nucleus network dynamics in parkinsonian mice during cortical slow-wave activity and activation. Kovaleski RF; Callahan JW; Chazalon M; Wokosin DL; Baufreton J; Bevan MD J Physiol; 2020 May; 598(10):1897-1927. PubMed ID: 32112413 [TBL] [Abstract][Full Text] [Related]
14. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease. Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672 [TBL] [Abstract][Full Text] [Related]
15. The subthalamic nucleus in the context of movement disorders. Hamani C; Saint-Cyr JA; Fraser J; Kaplitt M; Lozano AM Brain; 2004 Jan; 127(Pt 1):4-20. PubMed ID: 14607789 [TBL] [Abstract][Full Text] [Related]
16. Subthalamo-pallidal interactions underlying parkinsonian neuronal oscillations in the primate basal ganglia. Tachibana Y; Iwamuro H; Kita H; Takada M; Nambu A Eur J Neurosci; 2011 Nov; 34(9):1470-84. PubMed ID: 22034978 [TBL] [Abstract][Full Text] [Related]
17. Functional changes of the basal ganglia circuitry in Parkinson's disease. Blandini F; Nappi G; Tassorelli C; Martignoni E Prog Neurobiol; 2000 Sep; 62(1):63-88. PubMed ID: 10821982 [TBL] [Abstract][Full Text] [Related]
18. Basal ganglia and thalamic input from neurons located within the ventral tier cell cluster region of the substantia nigra pars compacta in the rat. Cebrián C; Prensa L J Comp Neurol; 2010 Apr; 518(8):1283-300. PubMed ID: 20151360 [TBL] [Abstract][Full Text] [Related]
19. Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat. Breit S; Bouali-Benazzouz R; Popa RC; Gasser T; Benabid AL; Benazzouz A Exp Neurol; 2007 May; 205(1):36-47. PubMed ID: 17395181 [TBL] [Abstract][Full Text] [Related]
20. Neuronal activity in the subthalamic nucleus modulates the release of dopamine in the monkey striatum. Shimo Y; Wichmann T Eur J Neurosci; 2009 Jan; 29(1):104-13. PubMed ID: 19087163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]